UroGen Pharma Q2 2026 Earnings Preview (NASDAQ:URGN)
· seekingalpha.com
UroGen Pharma (URGN) is scheduled to announce Q2 earnings results on Wednesday, August 5th, before market open. The consensus EPS Estimate is -$0.27 (+74.3% Y/Y
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...